Literature DB >> 28794595

Prevalence of diabetes mellitus after extra corporeal shock wave lithotripsy in 15 years follow-up.

Fahimeh Kazemi Rashed1, Nader Rash Ahmadi1, Ali Zolfaghari2, Alireza Farshi2, Mohsen Amjadi1, Mahboobeh Gholipour3.   

Abstract

OBJECTIVE: To investigate the hypothesis that extracorporeal shock wave lithotripsy (ESWL) increases the risk of new onset diabetes mellitus (DM) or significant changes in fasting blood sugar (FBS).
MATERIALS AND METHODS: A total number of 307 patients enrolled in this study. All of them had undergone ESWL for kidney stone from 1991 to 1994. In 2009, after 15-19 years, we invited patients to check their blood sugar.
RESULTS: There were 307 patients, 19.8% females, and 80.1% males. The mean age of the patients was 44 for females and 42 years for males. 47.5% had kidney stone in the left side, 42.9% in the right side and 9.4% bilateral. The mean FBS increasing was 11.86 g/dl. It was 14.54 g/dl for the right side, 8.57 g/dl for left and 16.24 g/dl for bilateral ESWL. DISCUSSIONS: The increasing of FBS is more significant in shock wave intensities higher than 15.5 KV. And there wasn't any significant relationship between age, sex, body mass index (BMI) and total number of shock waves with increasing of FBS. ESWL treatment might associate with increasing FBS without any relation to age, sex and BMI.

Entities:  

Keywords:  Diabetes mellitus; extracorporeal shock wave lithotripsy; fasting blood sugar

Year:  2017        PMID: 28794595      PMCID: PMC5532896          DOI: 10.4103/0974-7796.210041

Source DB:  PubMed          Journal:  Urol Ann        ISSN: 0974-7796


  20 in total

Review 1.  Management of kidney stones.

Authors:  Nicole L Miller; James E Lingeman
Journal:  BMJ       Date:  2007-03-03

2.  Blood pressure changes following extracorporeal shock wave lithotripsy and other forms of treatment for nephrolithiasis.

Authors:  J E Lingeman; J R Woods; P D Toth
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

3.  Thoracic spinal cord epidural hematoma after extracorporeal shock wave lithotripsy.

Authors:  Sang-Bok Lee; Tae-Gyu Lee; Do-Sung Yoo; Pil-Woo Huh; Kyoung-Suok Cho
Journal:  J Neurosurg Spine       Date:  2011-11-25

4.  Shock wave lithotripsy and diabetes mellitus: a population-based cohort study.

Authors:  Mitra de Cógáin; Amy E Krambeck; Andrew D Rule; Xujian Li; Eric J Bergstralh; Matthew T Gettman; John C Lieske
Journal:  Urology       Date:  2011-11-16       Impact factor: 2.649

5.  Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup.

Authors:  Amy E Krambeck; Matthew T Gettman; Audrey L Rohlinger; Christine M Lohse; David E Patterson; Joseph W Segura
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

Review 6.  Contemporary clinical practice of shock wave lithotripsy: a reevaluation of contraindications.

Authors:  S B Streem
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

7.  Extracorporeal shock wave lithotripsy as first line treatment for urinary tract stones in children: outcome of 500 cases.

Authors:  Abdelbasset A Badawy; Mohamed D Saleem; Ahmad Abolyosr; Mohamed Aldahshoury; Mohamed S B Elbadry; Medhat A Abdalla; Abdelmoneim M Abuzeid
Journal:  Int Urol Nephrol       Date:  2012-02-16       Impact factor: 2.370

8.  Shock wave lithotripsy for renal stones is not associated with hypertension and diabetes mellitus.

Authors:  Yoshikazu Sato; Hitoshi Tanda; Shuji Kato; Shigeki Ohnishi; Hisao Nakajima; Akihito Nanbu; Toshikazu Nitta; Mikio Koroku; Keigo Akagashi; Tatsuo Hanzawa
Journal:  Urology       Date:  2008-04       Impact factor: 2.649

Review 9.  The importance of beta-cell management in type 2 diabetes.

Authors:  E Standl
Journal:  Int J Clin Pract Suppl       Date:  2007-06

10.  Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones.

Authors:  Gunnar Wendt-Nordahl; Patrick Krombach; Dieter Hannak; Axel Häcker; Maurice Stephan Michel; Peter Alken; Thomas Knoll
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.